Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-010508
Filing Date
2025-03-05
Accepted
2025-03-05 16:31:51
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741210303.html 4  
1 FORM 4 wk-form4_1741210303.xml 4 5488
  Complete submission text file 0001628280-25-010508.txt   7063
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACELYRIN, INC. 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address
Dier Mardi (Reporting) CIK: 0001574591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 25711722